Doravirine/Islatravir for Initial HIV Therapy: A Two-Drug Strategy in a Three-Drug World
At CROI 2026, much of the discussion around antiretroviral therapy focused on long-acting agents and treatment optimization in experienced populations. Yet another important presentation turned to the starting point of care: initial therapy in people newly diagnosed with HIV.
25 二月 2026 13:00
Simplifying the Complex: Switching to BIC/LEN in Treatment-Experienced People with HIV
At CROI 2026, among presentations focused on prevention strategies and new antiviral approaches, one oral session addressed a different — and very practical — question in HIV care: what about people who are already virologically suppressed but remain on complex, ...
更多
24 二月 2026 15:00
Syphilis, Superbugs and Self-Testing: STIs in the Era of HIV Control
At CROI 2026, alongside discussions of metabolic therapies and inflammation, another plenary session brought the audience back to a more familiar reality. In her lecture, “Syphilis and Superbugs: Sexually Transmitted Infections in the Era of HIV Control,” ...
更多
U=U运动 (#UequalsU)
我的生活+在东欧和中亚地区组织的信息和教育活动 "U=U" （“无法检测到等于不可传播”，#UnqualsU，#НравноН）旨在传达一个信息，即HIV阳性者在病毒载量无法被检测到时，不能将病毒通过性行为传染给另一个人。
许多研究表明，在血清不一致的夫妇中，HIV阳性伴侣接受ARV治疗并保持无法检测到的病毒载量，则没有HIV性传播病例的发生。
我们的合作伙伴
